KING OF PRUSSIA, PA, June 21 /CNW/ - MDS Pharma Services, a leading
provider of innovative drug discovery and development solutions, has named
Howard Moody to the position of Vice-President of Information Technology (IT).
In this role, Mr. Moody will be responsible for implementing effective IT
applications to improve processes, increase operational efficiencies and fuel
business growth in MDS Pharma Services. Mr. Moody will report to MDS Pharma
Services President David Spaight and MDS Inc. Chief Information Officer (CIO)
"As a leading contract research organization, our business relies upon
having innovative IT applications to meet our customers' needs on a global
scale," said Mr. Spaight. "Mr. Moody's vast experience will enhance our
ability to offer our customers innovative IT solutions that support their drug
discovery and development initiatives."
Mr. Moody's background combines Clinical Laboratory and Contract Research
Organization (CRO) experience with more than 30 years of diverse IT positions.
Before joining MDS, Mr. Moody was Chief Information Officer at Medifacts
International, a CRO in Rockville, Maryland, where he was responsible for
global information technology and services.
Prior to that role, he worked for Churchill & Harriman, a pharmaceutical
company in Princeton, New Jersey, as a Senior Management Consultant. He spent
five years at Covance in Princeton, New Jersey, as Chief Information Officer
and Senior Vice-President. His experience also includes IT leadership roles at
Quest Diagnostics, SmithKline Beecham, and Deluxe Data Systems.
A native of New York, Mr. Moody earned a Bachelor of Science degree in
Mathematics from the State University of New York and a Master's degree in
Computer Science from the University of Wisconsin.
About MDS Pharma Services
MDS Pharma Services offers a full spectrum of resources to meet the drug
discovery and development needs of the pharmaceutical and biotechnology
industries. With numerous facilities strategically located around the world,
we apply advanced scientific and technological expertise throughout the drug
discovery and development process - from lead optimization, pre-IND research,
early clinical research (bioequivalence, phases I-IIa) and bioanalysis through
to global clinical development (phases IIb-IV), central lab and centralized
cardiac services. For more information, visit our website at www.mdsps.com.
MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ),
a global life sciences company that provides market-leading products and
services that our customers need for the development of drugs and diagnosis
and treatment of disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging, radiotherapeutics,
and analytical instruments. MDS has more than 6,200 highly skilled people in
28 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24
hours a day.
For further information:
For further information: For Investors, Sharon Mathers, (416) 675-6777
ext. 34721, firstname.lastname@example.org; For Media, Charlene McGrady, (610)
239-7900 ext. 231, email@example.com